25
Participants
Start Date
August 31, 2025
Primary Completion Date
August 31, 2026
Study Completion Date
August 31, 2026
ASV therapy
Adaptive servo ventilation (ASV) therapy using ResMed AirCurve 11 device will be used to target potential upper airway resistance and respiratory related arousals in patients with insomnia. The ASV device is approved for the treatment of obstructive sleep apnea, and this will be designated as the investigational device for this study with appropriate labelling.
C.S. Mott Center, Detroit
Lead Sponsor
ResMed
INDUSTRY